Home > Insider Trading > Filing (0001225208-11-007136)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1064863	Amerigroup Corp	AGP	Hospital & Medical Service Plans (6324)	541739323

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1024376	G James Carlson	4425 Corporation Lane Virginia Beach VA 23462	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-02-23	33,400	$15.63	250,880	No	4	M	Direct
Common Stock	Acquisiton	2011-02-23	26,830	$0.00	277,710	No	4	A	Direct
Common Stock	Acquisiton	2011-02-23	1,600	$15.63	279,310	No	4	M	Direct
Common Stock	Disposition	2011-02-23	1,600	$57.45	277,710	No	4	S	Direct
Common Stock	Disposition	2011-02-23	33,400	$56.91	244,310	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2011-02-23	1,600	$0.00	1,600	$15.63
Common Stock	Employee Stock Option (right to buy)	Disposition	2011-02-23	33,400	$0.00	33,400	$15.63

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
223,400	2006-05-13	2013-05-13	No	4	M	Direct
190,000	2006-05-13	2013-05-13	No	4	M	Direct

Footnotes

Transaction executed pursuant to 10(b)5-1 plan.
On May 13, 2010, the Issuer awarded 26,830 shares of restricted stock to the Reporting Person pursuant to the Issuer's 2009 Equity Incentive Plan, with such shares being subject to reduction at a rate of 2% of the shares for every $0.01 of diluted earnings per share less than $2.50 earned by the Issuer in 2010, as determined under U.S. generally accepted accounting principles, subject to certain adjustments. Based on the Issuer's $5.40 earnings per diluted share for the year ended December 31, 2010 as set forth in the Issuer's audited consolidated financial statements, the 26,830 shares of restricted stock shall not be reduced and 26,830 shares shall vest over four (4) years, with twenty-five percent (25%) vesting on April 30, 2011, and twenty-five percent (25%) vesting on April 30th of each year thereafter, such that all shares shall be vested on April 30, 2014, subject to Reporting Person's continued employment.
The transaction is a grant of Restricted Stock for which no consideration was paid.